Novel Cytosine Base Editor Restores Dystrophin Expression in DMD Mouse Model
核心洞察
Researchers have developed a novel cytosine base editor (aTdCBE (搜索)) that lacks adenosine deaminase activity, enhancing its precision in gene editing.
In a humanized mouse model of Duchenne muscular dystrophy (搜索) (DMD (搜索)), aTdCBE (搜索) effectively corrected exon 55 splicing by targeting the splice acceptor site.
Treatment with aTdCBE (搜索) led to nearly 99% restoration of dystrophin (搜索)-positive muscle fibers and approximately 60% restoration of dystrophin expression.
A novel cytosine base editor (CBE) has shown promise in restoring dystrophin (搜索) expression in a humanized mouse model of Duchenne muscular dystrophy (搜索) (DMD (搜索)). The study, conducted by researchers from HuidaGene Therapeutics (搜索) and other institutions in China and published in Nature Communications, addresses the challenge of existing tRNA-specific adenosine deaminase (TadA) variants exhibiting dual activity on both cytosine and adenosine bases. The newly developed aTdCBE (搜索) lacks adenosine deaminase activity, enhancing its precision for targeted gene editing.
The research focused on correcting exon 55 splicing in a DMD (搜索) mouse model with a deletion in exon 54 of the DMD gene. This deletion results in a premature stop codon in exon 55, leading to the production of a non-functional dystrophin (搜索) protein. The objective was to restore dystrophin expression by skipping exon 55 through precise cytosine base editing at the exon 55 splice acceptor site (SAS).
Efficacy of aTdCBE in DMD Mouse Model
Following in vivo delivery of aTdCBE (搜索), DNA base editing at the exon 55 splice acceptor site reached over 40% after six weeks, indicating effective editing of the DMD (搜索) gene. Immunostaining revealed that dystrophin (搜索)-positive muscle fibers reached almost 99% of wild-type levels. Western blot analysis confirmed approximately 60% restoration of dystrophin expression.
Molecular Confirmation of Dystrophin Restoration
RT-PCR analysis further validated successful exon 55 skipping, restoring the correct reading frame of the DMD (搜索) gene. This led to the production of functional dystrophin (搜索) protein, demonstrating efficient gene editing and significant dystrophin restoration in the treated mice. These results suggest a potential therapeutic strategy for DMD by precisely correcting genetic mutations at the DNA level.
Implications for DMD Treatment
Duchenne muscular dystrophy (搜索) is a severe genetic disorder characterized by progressive muscle degeneration and weakness. Current treatments offer limited efficacy, highlighting the urgent need for innovative therapeutic approaches. This study introduces a promising gene editing strategy that could potentially address the underlying genetic cause of DMD (搜索), offering a more effective and targeted treatment option.